Ran Nussbaum

Ran Nussbaum

Director/Board Member at LB PHARMACEUTICALS INC

Net worth: 57 960 $ as of 2026-10-30

53 year
Health Technology
Finance
Health Services

Profile

Ran Nussbaum is the founder of Pontifax Management Co. Ltd., founded in 2004, serving as Managing Partner.
Mr. Nussbaum is the founder of Pontifax Group, founded in 2004, serving as Managing Partner.
Current jobs include Director at Pontifax Management 2 G.P.
(2007) Ltd., Pontifax (Israel) IV LP, Anaveon AG, Lutris Pharma Ltd., Indapta Therapeutics, Inc., Graviton Bioscience Corp., Orvida Pharma Ltd., and Advisory Committee member at Aliment Capital LLC.
Managing Partner at Pontifax Management 4 Gp 2015 Ltd. Independent Director at LB Pharmaceuticals, Inc. since 2023.
Former jobs include Chairman & Chief Executive Officer at BioMedix, Inc. from 2006 to 2008; Chief Executive Officer at Spearhead, LLC from 2009 to 2010; Chairman at SciSparc Ltd. from 2007 to 2010; Chairman at Spearhead Investments (Bio) Ltd.; Chairman at OCON Medical Ltd.; Director at ArQule, Inc., Bioblast Pharma Ltd., CollPlant Ltd., Nutrinia Ltd., Quiet Therapeutics Ltd., Eloxx Pharmaceuticals Ltd., Fore Biotherapeutics, Inc., N T B Pharma Ltd., Zolex Therapeutics Ltd., Pontifax (Cayman) III LP, Pontifax (Israel) III LP, and SciSparc Ltd. Director at ProtAb Ltd. from 2010 to 2014; Director at Erech Finance Cahalacha Ltd. from 2013 to 2015; Director at CollPlant Biotechnologies Ltd. from 2010 to 2014; Independent Director at Kite Pharma, Inc. from 2014 to 2017; Director at cCAM Biotherapeutics Ltd. from 2012 to 2015; Independent Director at UroGen Pharma Ltd. from 2013 to 2023; Director at Fusimab Ltd. from 2010 to 2014; Director at VBI Vaccines, Inc. from 2017 to 2018; Independent Director at Eloxx Pharmaceuticals, Inc. from 2017 to 2022; Independent Director at Prevail Therapeutics, Inc. from 2018 to 2021; Independent Director at Keros Therapeutics, Inc. from 2023 to 2025.

Known holdings in public companies

CompanyDateNumber of sharesValuationValuation date
2025-10-14 5,250 ( 0.03% ) 57 960 $ 2026-10-30

Ran Nussbaum active positions

CompaniesPositionStart
LB PHARMACEUTICALS INC Director/Board Member 2023-07-31
Founder 2003-12-31
Pontifax Group
Founder 2004-11-30
Pontifax Management 2 G.P. (2007) Ltd.
Director/Board Member -
Director/Board Member -
Director/Board Member -
Director/Board Member -
Director/Board Member -
Director/Board Member -
░░░░░░ ░░░░░░ ░░░░ ░░░░░░░░░░░░░░ ░░░░░░ -

Former positions of Ran Nussbaum

CompaniesPositionEnd
░░░░░ ░░░░░░░░░░░░░ ░░░░ ░░░░░░░░ ░░░░░░░░░░
░░░░░░ ░░░░░░ ░░░░ ░░░░░░░░░░░░░░ ░░░░░░ ░░░░░░░░░░
░░░░░ ░░░░░░░░░░░░░░░░ ░░░░ ░░░░░░░░░░░░░░ ░░░░░░ ░░░░░░░░░░
░░░░░░░ ░░░░░░░░░░░░ ░░░░ ░░░░░░░░░░░░░░ ░░░░░░ ░░░░░░░░░░
░░░ ░░░░░░░░ ░░░░ ░░░░░░░░░░░░░░ ░░░░░░ ░░░░░░░░░░
See the detail of Ran Nussbaum's experience

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

Connections

56

1st degree connections

39

1st degree companies

Male

Female

Members of the board

Executives

Linked companies

Private companies39

Health Technology

Health Technology

Spearhead, LLC

Health Technology

Finance

Health Technology

Health Technology

Health Technology

Health Technology

Spearhead Investments (Bio) Ltd.

Health Technology

Health Technology

Health Technology

Health Technology

Health Technology

Health Technology

Health Services

Fusimab Ltd.

Health Technology

Pontifax Group

Pontifax Management 2 G.P. (2007) Ltd.

Health Technology

Health Technology

Finance

Health Technology

Commercial Services

Health Technology

Health Technology

Finance

Finance

Finance

Health Technology

Pontifax Management 4 Gp 2015 Ltd.

Health Technology

Health Technology

Health Technology

Health Technology

Health Technology

Health Technology